Palatin Technologies, Inc. Common Stock Total Liabilities
Palatin Technologies, Inc. Common Stock total liabilities. Based on the latest financial reports, Palatin Technologies, Inc. Common Stock (PTN) has total liabilities worth $2.63 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check how resilient are Palatin Technologies, Inc. Common Stock's assets to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Palatin Technologies, Inc. Common Stock (1996–2025)
Total liabilities of Palatin Technologies, Inc. Common Stock from 1996 to 2025. This chart illustrates how Palatin Technologies, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.
Palatin Technologies, Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of Palatin Technologies, Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
LDT Inc
KQ:096870
|
Korea | ₩2.45 Billion |
|
Zyrexindo Mandiri Buana PT Tbk
JK:ZYRX
|
Indonesia | Rp496.67 Billion |
|
Kordellos Ch. Bros S.A
AT:KORDE
|
Greece | €38.84 Million |
|
Radiopharm Theranostics Ltd
AU:RAD
|
Australia | AU$37.81 Million |
|
HiteJinro Co Ltd
KO:000087
|
Korea | ₩2.19 Trillion |
|
Quhuo Limited
NASDAQ:QHUOD
|
USA | $448.76 Million |
|
Siamraj Public Company Limited
BK:SR
|
Thailand | ฿1.25 Billion |
|
Baselode Energy Corp
V:FIND
|
Canada | CA$5.71 Million |
Liability Composition Analysis (1996–2025)
This chart breaks down Palatin Technologies, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PTN current and non-current assets.
Liquidity & Leverage Metrics
Palatin Technologies, Inc. Common Stock Total Liabilities Ratios Explained
Palatin Technologies, Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.04 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Palatin Technologies, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Palatin Technologies, Inc. Common Stock (1996–2025)
The table below shows the annual total liabilities of Palatin Technologies, Inc. Common Stock from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $8.04 Million | -25.89% |
| 2024-06-30 | $10.85 Million | -45.51% |
| 2023-06-30 | $19.92 Million | +0.59% |
| 2022-06-30 | $19.80 Million | +12.23% |
| 2021-06-30 | $17.65 Million | +261.52% |
| 2020-06-30 | $4.88 Million | +16.60% |
| 2019-06-30 | $4.19 Million | -65.27% |
| 2018-06-30 | $12.05 Million | -80.56% |
| 2017-06-30 | $62.00 Million | +116.49% |
| 2016-06-30 | $28.64 Million | +65.82% |
| 2015-06-30 | $17.27 Million | +523.41% |
| 2014-06-30 | $2.77 Million | +32.18% |
| 2013-06-30 | $2.10 Million | -40.96% |
| 2012-06-30 | $3.55 Million | +19.07% |
| 2011-06-30 | $2.98 Million | -2.92% |
| 2010-06-30 | $3.07 Million | -68.94% |
| 2009-06-30 | $9.89 Million | -21.37% |
| 2008-06-30 | $12.57 Million | -48.15% |
| 2007-06-30 | $24.25 Million | +11.50% |
| 2006-06-30 | $21.75 Million | -16.17% |
| 2005-06-30 | $25.94 Million | +419.61% |
| 2004-06-30 | $4.99 Million | +22.83% |
| 2003-06-30 | $4.06 Million | +10.71% |
| 2002-06-30 | $3.67 Million | +57.67% |
| 2001-06-30 | $2.33 Million | +17.59% |
| 2000-06-30 | $1.98 Million | -54.99% |
| 1999-06-30 | $4.40 Million | +41.94% |
| 1998-06-30 | $3.10 Million | -27.91% |
| 1997-06-30 | $4.30 Million | +2.31% |
| 1996-06-30 | $4.20 Million | -- |
About Palatin Technologies, Inc. Common Stock
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, … Read more